Iressa and Radiotherapy in the treatment of the locally advanced inoperable squamous cell carcinoma of the head and neck

Study identifier:1839IL/0070

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A 2 part phase 2 trial to evaluate ZD1839 (Iressa™) & radiotherapy in patients w/locally advanced inoperable squamous cell carcinoma of the head & neck

Medical condition

head and neck cancer

Phase

Phase 2

Healthy volunteers

No

Study drug

Iressa (Gefitinib)

Sex

All

Actual Enrollment

28

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jul 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria